vs
Side-by-side financial comparison of Beeline Holdings, Inc. (BLNE) and Bolt Biotherapeutics, Inc. (BOLT). Click either name above to swap in a different company.
Bolt Biotherapeutics, Inc. is the larger business by last-quarter revenue ($2.5M vs $1.9M, roughly 1.3× Beeline Holdings, Inc.). Bolt Biotherapeutics, Inc. runs the higher net margin — -265.2% vs -445.0%, a 179.7% gap on every dollar of revenue. Over the past eight quarters, Bolt Biotherapeutics, Inc.'s revenue compounded faster (-31.2% CAGR vs -33.0%).
Beeline or билайн is a mobile network operator brand operating in Russia under PJSC VimpelCom, and in Kazakhstan, Kyrgyzstan and Uzbekistan under VEON Ltd. Beeline is Russia's fourth-largest mobile network operator, and main competitors being MTS, MegaFon and T2.
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.
BLNE vs BOLT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.9M | $2.5M |
| Net Profit | $-8.4M | $-6.6M |
| Gross Margin | — | — |
| Operating Margin | -418.4% | -283.4% |
| Net Margin | -445.0% | -265.2% |
| Revenue YoY | — | — |
| Net Profit YoY | -16.1% | 58.4% |
| EPS (diluted) | — | $-9.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9M | $2.5M | ||
| Q3 25 | $2.3M | $2.2M | ||
| Q2 25 | $1.7M | $1.8M | ||
| Q1 25 | $1.8M | $1.2M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $783.0K | $1.1M | ||
| Q2 24 | $3.1M | $1.3M | ||
| Q1 24 | $2.5M | $5.3M |
| Q4 25 | $-8.4M | $-6.6M | ||
| Q3 25 | $-3.9M | $-7.1M | ||
| Q2 25 | $-4.1M | $-8.6M | ||
| Q1 25 | $-6.8M | $-11.0M | ||
| Q4 24 | — | $-15.9M | ||
| Q3 24 | $-1.4M | $-15.2M | ||
| Q2 24 | $-1.5M | $-21.2M | ||
| Q1 24 | $-1.3M | $-10.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.5% | — | ||
| Q2 24 | 5.0% | — | ||
| Q1 24 | 7.5% | — |
| Q4 25 | -418.4% | -283.4% | ||
| Q3 25 | -120.9% | -355.1% | ||
| Q2 25 | -229.0% | -510.5% | ||
| Q1 25 | -268.7% | -991.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -55.6% | -1441.1% | ||
| Q2 24 | -11.4% | -1772.3% | ||
| Q1 24 | -18.5% | -324.1% |
| Q4 25 | -445.0% | -265.2% | ||
| Q3 25 | -167.2% | -329.4% | ||
| Q2 25 | -237.3% | -474.6% | ||
| Q1 25 | -372.4% | -903.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -173.6% | -1330.1% | ||
| Q2 24 | -48.6% | -1662.4% | ||
| Q1 24 | -52.0% | -205.0% |
| Q4 25 | — | $-9.38 | ||
| Q3 25 | $-0.20 | $-3.72 | ||
| Q2 25 | $-0.64 | $-4.46 | ||
| Q1 25 | — | $-0.29 | ||
| Q4 24 | — | $-13.73 | ||
| Q3 24 | $-6.60 | $-7.93 | ||
| Q2 24 | $-8.74 | $-11.12 | ||
| Q1 24 | $-0.78 | $-0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.1M | $27.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $53.6M | $26.5M |
| Total Assets | $70.2M | $56.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.1M | $27.5M | ||
| Q3 25 | $1.3M | $31.9M | ||
| Q2 25 | $6.3M | $34.8M | ||
| Q1 25 | $1.5M | $38.8M | ||
| Q4 24 | — | $47.3M | ||
| Q3 24 | $310.0K | $53.8M | ||
| Q2 24 | $420.0K | $73.7M | ||
| Q1 24 | $147.0K | $91.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $8.1M | — | ||
| Q1 24 | $8.1M | — |
| Q4 25 | $53.6M | $26.5M | ||
| Q3 25 | $51.7M | $32.1M | ||
| Q2 25 | $54.6M | $38.8M | ||
| Q1 25 | $47.1M | $46.8M | ||
| Q4 24 | — | $57.2M | ||
| Q3 24 | $-2.5M | $72.0M | ||
| Q2 24 | $-1.9M | $85.9M | ||
| Q1 24 | $-476.0K | $104.2M |
| Q4 25 | $70.2M | $56.7M | ||
| Q3 25 | $63.2M | $65.1M | ||
| Q2 25 | $68.6M | $75.5M | ||
| Q1 25 | $63.8M | $85.9M | ||
| Q4 24 | — | $99.6M | ||
| Q3 24 | $16.2M | $109.3M | ||
| Q2 24 | $16.6M | $124.2M | ||
| Q1 24 | $17.0M | $142.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-21.4M | $-7.2M |
| Free Cash FlowOCF − Capex | $-21.5M | — |
| FCF MarginFCF / Revenue | -1143.3% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-21.4M | $-7.2M | ||
| Q3 25 | $-5.8M | $-9.7M | ||
| Q2 25 | $-4.1M | $-9.6M | ||
| Q1 25 | $-1.5M | $-13.4M | ||
| Q4 24 | — | $-14.4M | ||
| Q3 24 | $-652.0K | $-14.0M | ||
| Q2 24 | $-872.0K | $-16.1M | ||
| Q1 24 | $-82.0K | $-16.8M |
| Q4 25 | $-21.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -1143.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1227.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLNE
| Beeline Title Holdings | $1.4M | 73% |
| Other | $498.0K | 27% |
BOLT
Segment breakdown not available.
